Streetbeat News

Earnings

RGA

Reinsurance Gr (NYSE:RGA) reported Q2 earnings of $4.40 per share, beating the analyst consensus estimate of $4.14 by 6.28%. However, this is a 23.88% decrease from the same period last year. The company's quarterly sales were $4.16 billion, missing the analyst consensus estimate of $4.28 billion by 2.90%, but showing a 6.92% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 2:30 pm

CTRE

CareTrust REIT (NASDAQ:CTRE) reported Q2 earnings of $0.35 per share, a 5.41% decrease YoY. However, the company's quarterly sales of $51.55 million beat the analyst consensus estimate of $51.50 million by 0.10%, marking an 8.41% increase YoY.

Portfolio Pulse from totan@benzinga.com

August 04, 2023 | 2:30 pm

TMDX

TransMedics Gr (NASDAQ:TMDX) reported Q2 EPS of $(0.03), beating the analyst consensus estimate of $(0.13) by 76.92%. This is a 92.68% increase over losses from the same period last year. The company also reported quarterly sales of $52.47M, beating the analyst consensus estimate of $42.42M by 23.68%. This is a 155.66% increase over sales from the same period last year.

Portfolio Pulse from bharat@benzinga.com

August 04, 2023 | 2:30 pm

AAPL

Apple CEO Tim Cook announced that the company achieved an all-time revenue record in Services during the June quarter, driven by over 1 billion paid subscriptions. He also noted robust sales of iPhone in emerging markets.

Portfolio Pulse from Happy Mohamed

August 04, 2023 | 2:30 pm

VXRT

Vaxart (NASDAQ:VXRT) reported Q2 losses of $(0.16) per share, beating the analyst consensus estimate of $(0.18) by 11.11%. This is a 30.43% increase over losses from the same period last year. The company also reported quarterly sales of $1.36 million, beating the analyst consensus estimate of $80.00 thousand by 1.60K%.

Portfolio Pulse from totan@benzinga.com

August 04, 2023 | 2:30 pm

AMN

AMN Healthcare Services reported Q2 earnings of $2.38 per share, beating the analyst consensus estimate of $2.14 by 11.21%. However, this is a 28.1% decrease from the same period last year. The company also reported quarterly sales of $991.30 million, beating the estimate of $988.40 million by 0.29%, but this is a 30.53% decrease from last year.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 2:30 pm

TVTX

Travere Therapeutics reported Q2 adjusted EPS of $(0.77), beating the estimate of $(1.16) by 33.62%. The company also reported sales of $59.70M, surpassing the estimate of $53.93M by 10.69%. However, this represents an 18.46% decrease in EPS and a 10.21% increase in sales compared to the same period last year.

Portfolio Pulse from bharat@benzinga.com

August 04, 2023 | 2:30 pm

SRTS

Sensus Healthcare reported Q2 losses of $(0.02) per share, beating the analyst consensus estimate of $(0.08) by 75%. However, the company's quarterly sales of $4.53 million missed the analyst consensus estimate of $4.55 million by 0.51%. This represents a 109.52% decrease in earnings and a 62.52% decrease in sales compared to the same period last year.

Portfolio Pulse from totan@benzinga.com

August 04, 2023 | 2:29 pm

MODV

ModivCare has updated its revenue and adjusted EBITDA guidance for FY23. The company now expects revenue to be between $2.75 billion and $2.8 billion, up from the previous estimate of $2.575 billion to $2.6 billion. However, the adjusted EBITDA guidance has been lowered to $200 million to $210 million from the previous $225 million to $235 million.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 2:29 pm

CPT

Camden Prop Trust (NYSE:CPT) reported Q2 earnings of $1.67 per share, a 1.83% increase YoY. The company also reported quarterly sales of $385.50 million, beating the analyst consensus estimate of $383.52 million by 0.52% and marking a 6.58% increase YoY.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 2:29 pm